Cite
McDonald A, Steiner R, Kuehl K, et al. Clinical utility of endurance measures for evaluation of treatment in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). J Pediatr Rehabil Med. 2010;3(2):119-27doi: 10.3233/PRM-2010-0114.
McDonald, A., Steiner, R., Kuehl, K., & Turbeville, S. (2010). Clinical utility of endurance measures for evaluation of treatment in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Journal of pediatric rehabilitation medicine, 3(2), 119-27. https://doi.org/10.3233/PRM-2010-0114
McDonald, Arline, et al. "Clinical utility of endurance measures for evaluation of treatment in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)." Journal of pediatric rehabilitation medicine vol. 3,2 (2010): 119-27. doi: https://doi.org/10.3233/PRM-2010-0114
McDonald A, Steiner R, Kuehl K, Turbeville S. Clinical utility of endurance measures for evaluation of treatment in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). J Pediatr Rehabil Med. 2010;3(2):119-27. doi: 10.3233/PRM-2010-0114. PMID: 21791839.
Copy
Download .nbib